Cresco Labs (CSE: CL) (OTCQX: CRLBF) - Investor Dashboard
| ➔ Cresco Labs | |||||
|---|---|---|---|---|---|
| CSE Ticker: | CL | ||||
| OTCQX Ticker: | CRLBF | ||||
| Sector: | Healthcare |
| Industry: | CPG |
| Country: | Canada/U.S. |
| Employees: | 550 as of 03/1/19 |
| Established: | 2013 |
| CEO: | Charles Bachtell |
Cresco Labs – Recent Financing
- 11/26/18 – Size: $107 million – Security: 12.6 million subordinated voting shares – Price: C$8.50
- 10/04/18 – Size: $100 million – Security: 26.7 million subordinated voting shares – Price: C$3.75
- 05/20/18 – Size: $24 million – Security: 10.7 million subordinated voting shares – Price: C$2.25
- 01/16/18 – Size: $0.6 million – Security: 0.5 million subordinated voting shares – Price: C$1.14
- 11/27/17 – Size: $16 million – Security: 14.0 million subordinated voting shares – Price: C$1.14
Visit Cresco Labs, Inc.
at www.crescolabs.com.
New Cannabis Ventures in partnership with due diligence platform 420Investor, is the definitive source for fact-based, data-driven, financial information and relevant company news for qualified publicly traded cannabis companies. NCV extracts and parses only the most important content. Information is provided “as is” and solely for informational purposes, not for trading or advice. Cresco Labs, Inc. is a client of NCV Media, LLC. Read our full disclaimer.